KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY;한국과학기술연구원;GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY;광주과학기술원
发明人:
PARK, Ki Duk,박기덕,CHO, Jongwook,조종욱,LEE, Changjoon,이창준,OH, Soo-Jin,오수진,PAE, Ae Nim,배애님,LIM, Sang Min,임상민,PARK, Jong Hyun,박종현,NAM, Min-Ho,남민호,KIM, Hyoung Ihl,김형일,PARK, Ji Young,박지영
申请号：
KRKR2019/003794
公开号：
WO2019/194494A1
申请日:
2019.04.01
申请国别(地区):
KR
年份:
2019
代理人:
摘要：
The present invention relates to a pharmaceutical composition comprising (S)-2-(((4'-trifluoromethylbiphenyl-4-yl)methyl)amino)propanamide methanesulfonate or a pharmaceutically acceptable salt thereof as an effective ingredient for prevention or treatment of stroke.La présente invention concerne une composition pharmaceutique comprenant le méthanesulfonate du (S)-2-(((4'-trifluorométhylbiphényl-4-yl)méthyl)amino)propanamide ou un sel pharmaceutiquement acceptable de celui-ci utilisé comme principe actif pour la prévention ou le traitement d'un accident vasculaire cérébral.본 발명은 (S)-2-(((4'-트리플루오로메틸바이페닐-4-일)메틸)아미노)프로판아미드 메탄설포네이트를 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 포함하는, 뇌졸중 (stroke)의 예방 또는 치료용 약학 조성물 등에 관한 것이다.
